BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kirstein MM, Wirth TC. Multimodale Therapie des hepatozellulären Karzinoms. Internist 2020;61:164-9. [DOI: 10.1007/s00108-019-00722-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Dong X, Han Y, Zhang E, Wang Y, Zhang P, Wang C, Zhong L, Li Q. Tumor suppressor DCAF15 inhibits epithelial-mesenchymal transition by targeting ZEB1 for proteasomal degradation in hepatocellular carcinoma. Aging (Albany NY) 2021;13:10603-18. [PMID: 33833131 DOI: 10.18632/aging.202823] [Reference Citation Analysis]
2 Lu Y, Wang Y, He Y, Pan J, Jin Y, Zheng L, Huang Y, Li Y, Liu W. Aidi injection altered the activity of CYP2D4, CYP1A2, CYP2C19, CYP3A2, CYP2E1 and CYP2C11 in normal and diethylnitrosamine-induced hepatocellular carcinoma in rats. J Ethnopharmacol 2021;:114930. [PMID: 34952190 DOI: 10.1016/j.jep.2021.114930] [Reference Citation Analysis]
3 Becker LS, Maschke SK, Dewald CLA, Meine TC, Winther HBM, Kirstein MM, Kloeckner R, Meyer BC, Wacker F, Hinrichs JB. Two-dimensional parametric parenchymal blood flow in transarterial chemoembolisation for hepatocellular carcinoma: perfusion change quantification and tumour response prediction at 3 months post-intervention. Clin Radiol 2021;76:160.e27-33. [PMID: 33028487 DOI: 10.1016/j.crad.2020.09.012] [Reference Citation Analysis]
4 Hu J, Cai D, Zhao Z, Zhong GC, Gong J. Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway. Front Oncol 2021;11:659676. [PMID: 33937074 DOI: 10.3389/fonc.2021.659676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu W, Xu C, Meng Q, Kang P. The clinical value of kinesin superfamily protein 2A in hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 2021;45:101527. [PMID: 33713978 DOI: 10.1016/j.clinre.2020.08.005] [Reference Citation Analysis]
6 Wang X, Ge Y, Shi M, Dai H, Liu W, Wang P. Protein kinase N1 promotes proliferation and invasion of liver cancer. Exp Ther Med 2021;21:651. [PMID: 33968181 DOI: 10.3892/etm.2021.10083] [Reference Citation Analysis]
7 Yang G, Xu Q, Wan Y, Zhang L, Wang L, Meng F. Circ-CSPP1 knockdown suppresses hepatocellular carcinoma progression through miR-493-5p releasing-mediated HMGB1 downregulation. Cell Signal 2021;86:110065. [PMID: 34182091 DOI: 10.1016/j.cellsig.2021.110065] [Reference Citation Analysis]
8 Dakua SP, Nayak A. A review on treatments of hepatocellular carcinoma—role of radio wave ablation and possible improvements. Egypt Liver Journal 2022;12. [DOI: 10.1186/s43066-022-00191-2] [Reference Citation Analysis]
9 Li Y, Xiong H. Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K/AKT/mTOR and Ras/RAF/MAPK pathways. BMC Cancer 2022;22:298. [PMID: 35313850 DOI: 10.1186/s12885-022-09398-3] [Reference Citation Analysis]
10 Mekuria AN, Tura AK, Hagos B, Sisay M, Abdela J, Mishore KM, Motbaynor B. Anti-Cancer Effects of Lycopene in Animal Models of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Front Pharmacol 2020;11:1306. [PMID: 32982734 DOI: 10.3389/fphar.2020.01306] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Swed B, Gandarilla O, Chiu K, Halazun KH, Samstein B, Yantiss R, Brar G. Rare Histological Variants of Liver Cancer and Their Management: A Single-Institution Experience. Case Reports Hepatol 2021;2021:6654229. [PMID: 33968454 DOI: 10.1155/2021/6654229] [Reference Citation Analysis]